ProUroCare Announces New Board of Directors Member
ProUroCare Medical Inc
September 9, 2013
ProUroCare Medical Inc. (OTCQB: PUMD) is pleased to announce the appointment of David Kaysen as a member of its Board of Directors effective September 9, 2013. From May 2006 until April 2013, Mr. Kaysen was President, CEO and a director of Uroplasty, Inc. a Nasdaq listed medical device company that develops, manufactures and markets innovative, proprietary products for the treatment of voiding dysfunctions. From July 2005 to May 2006, Mr. Kaysen served as President, CEO and a director of Advanced Duplication Services, LLC, a privately-held replicator and duplicator of optical media. Between December 2002 and June 2005, he served as President, CEO and a director of Diametrics Medical, Inc., then a publicly-traded manufacturer and marketer of critical blood analysis systems that provided continuous diagnostic results at point of patient care. From 1992 to 2002, Mr. Kaysen served as President, CEO and a director of Rehabilicare Inc., then a publicly-traded manufacturer and marketer of electromedical rehabilitation and pain management products for clinician, home and industrial use.
Jim Davis, Chairman of the Board of Directors stated "Mr. Kaysen's broad and extensive experience as an executive officer of publicly traded medical device companies in a wide variety of specialties, as a director of public companies, and as a sales manager of multi-national medical companies will be very beneficial to the future growth of the company".
About ProUroCare Medical Inc.
ProUroCare Medical Inc. is a publicly traded company engaged in the business of creating innovative medical imaging products. The company’s ProUroScan system, an elasticity imaging technology used to document abnormalities of the prostate previously detected by a digital rectal examination, received commercial clearance from the FDA in April 2012. Based in Minneapolis, the company’s stock trades on the OTCQB market (www.otcmarkets.com).
Eden Prairie Firm Wins Approval to Sell Prostate Imaging Technology
Minneapolis Star Tribune
May 27, 2012
CEO Rick Carlson and Director Larry Getlin are interviewed in this article about the FDA approval of the ProUroScan prostate imaging system.
FDA Clears ProUroCare’s New Prostate Mechanical Imaging System
May 2, 2012
An article that appeared on News-Medical.net concerning FDA approval of the ProUroScan.
FDA Approves Device That was Developed in the Twin Cities
KSTP TV, Minneapolis
May 2, 2012
From KSTP's evening news, a discussion of the ProUroScan's approval and what it means for prostate disease patients.
ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System
May 1, 2012
An article that appeared on DeviceSpace.Com concerning FDA approval of the ProUroScan.
Prostate Cancer is a Manageable Disease
September 25, 2009
CEO Rick Carlson and Dr. Robert Weiss are quoted in this article about managing prostate cancer and detection options which also mentions the ProUroScan system.
Aaron Berstler, Kohnstamm Communications, 651.789.1264
Rick Carlson, CEO, 952.698.1160
Press kit fact sheets: